Clinical Trial Detail

NCT ID NCT02763254
Title Cellular Immunotherapy for Viral Induced Cancer - EBV Positive Lymphomas (CIVIC)
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements no
Sponsors Cell Medica Ltd
Indications

Hodgkin's lymphoma

diffuse large B-cell lymphoma

Therapies

CMD-003

Age Groups: adult child senior

No variant requirements are available.